WOOFPetco Health and Wellness Company, Inc.
Is the price fair?
Undemanding: modest expectations priced in and cheap against its own history.
Priced for a decline (~−24% a year). Little growth is priced in even as revenue fell 1% a year over three years, potential value, or a value trap.
Cheap vs its own history: P/E 22.4 vs a 39.4 median over 12 quarters (−43% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What WOOF's price assumes
Petco Health and Wellness Company, Inc. trades at 22.4× earnings against 19.5× for the median Specialty Retail name, more expensive than its own group.
Trailing P/E · Specialty Retail median 19.5 · 1.15× the median: the market pays up for this one
- Price / sales
- 0.12
Price / sales · as of 2026-Q2
- Free cash flow yield
- 37%
Free cash flow yield · Specialty Retail median 5.8%
- Growth the price implies
- −24%
Growth the price implies · The price pays for −24% free cash flow growth a year for a decade; the business has delivered +24% a year over the last three.
Details›
- Price / bookas of 2026-Q2
- 0.61
- EV / EBIToperating margin 2.2%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 0.56
- Consumer Cyclical median P/E321 names
- 17.9
- Specialty Retail median P/E25 names
- 19.5
- Free cash flow, trailing twelve months
- $238M
- Market capitalisation
- $641M
- 3-year revenue growth
- −1.1%
- 3-year free cash flow growth
- +24%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $3.06 |
| Its own P/E history, median | $3.94 |
| Its own P/E history, upper quartile | $6.50 |
| 52-week range | $2.18 – $3.82 |
| Today | $2.25 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.